Evidence map›Paper›PMID 34564446›Full record

ArticleMetabolites2021

A New Pipeline for the Normalization and Pooling of Metabolomics Data.

Vivian Viallon, Mathilde His, Sabina Rinaldi, Marie Breeur, Audrey Gicquiau, Bertrand Hemon, Kim Overvad, Anne Tjønneland, Agnetha Linn Rostgaard-Hansen, Joseph A Rothwell and 37 more

Abstract read
In one paragraph

Article in Metabolites, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Metabolic profile of biodiverse diets in a healthy European cohort.The American journal of clinical nutrition · 2025
    Article
  4. Article
  5. Identifying Metabolomic Mediators of the Physical Activity and Colorectal Cancer Relationship.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

47 authors.

Vivian ViallonNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.ORCID 0000-0002-9799-4421
Mathilde HisNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.
Sabina RinaldiNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.
Marie BreeurNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.
Audrey GicquiauNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.
Bertrand HemonNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.
Kim OvervadDepartment of Public Health, Aarhus University Bartholins Alle 2, DK-8000 Aarhus, Denmark.
Anne TjønnelandDanish Cancer Society Research Center, DK-2100 Copenhagen, Denmark.ORCID 0000-0003-4385-2097
Agnetha Linn Rostgaard-HansenDanish Cancer Society Research Center, DK-2100 Copenhagen, Denmark.
Joseph A RothwellUVSQ, Inserm, CESP U1018, "Exposome and Heredity" Team, Université Paris-Saclay, Gustave Roussy, 94800 Villejuif, France.
Lucie LecuyerUVSQ, Inserm, CESP U1018, "Exposome and Heredity" Team, Université Paris-Saclay, Gustave Roussy, 94800 Villejuif, France.ORCID 0000-0001-8033-450X
Gianluca SeveriUVSQ, Inserm, CESP U1018, "Exposome and Heredity" Team, Université Paris-Saclay, Gustave Roussy, 94800 Villejuif, France.ORCID 0000-0001-7157-419X
Rudolf KaaksDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Theron JohnsonDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Matthias B SchulzeDepartment of Molecular Epidemiology, German Institute of Human Nutrition Potsdam Rehbruecke, Arthur-Scheunert-Allee 114-116, 14558 Nuthetal, Germany.ORCID 0000-0002-0830-5277
Domenico PalliCancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), 50139 Florence, Italy.ORCID 0000-0002-5558-2437
Claudia AgnoliEpidemiology and Prevention Unit Department of Research, Fondazione IRCCS-Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Salvatore PanicoDipartimento di Medicina Clinica e Chirurgia, Federico II University, 80131 Naples, Italy.
Rosario TuminoCancer Registry and Histopathology Department, Provincial Health Authority (ASP 7), 97100 Ragusa, Italy.ORCID 0000-0003-2666-414X
Fulvio RicceriDepartment of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.ORCID 0000-0001-8749-9737
W M Monique VerschurenNational Institute for Public Health and the Environment, Centre for Nutrition, Prevention and Health Services, Antonie van Leeuwenhoeklaan 9, 3721 MA Bilthoven, The Netherlands.
Peter EngelfrietNational Institute for Public Health and the Environment, Centre for Nutrition, Prevention and Health Services, Antonie van Leeuwenhoeklaan 9, 3721 MA Bilthoven, The Netherlands.
Charlotte Onland-MoretJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, 3584 CG Utrecht, The Netherlands.
Roel VermeulenJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, 3584 CG Utrecht, The Netherlands.
Therese Haugdahl NøstDepartment of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, P.O. Box 6050, 9037 Tromsø, Norway.
Ilona UrbarovaDepartment of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, P.O. Box 6050, 9037 Tromsø, Norway.
Raul Zamora-RosUnit of Nutrition and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), 08908 L'Hospitalet de Llobregat, Spain.ORCID 0000-0002-6236-6804
Miguel Rodriguez-BarrancoEscuela Andaluza de Salud Pública (EASP), 18011 Granada, Spain.
Pilar AmianoCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.
José Maria HuertaCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.ORCID 0000-0002-9637-3869
Eva ArdanazCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.
Olle MelanderDepartment of Clincal Sciences, Lund University, SE-21 428 Malmö, Sweden.
Filip OttosonDepartment of Immunotechnology, Lund University, SE-22 100 Lund, Sweden.ORCID 0000-0002-8312-3545
Linda VidmanDepartment of Radiation Sciences, Oncology, Umeå University, SE-901 87 Umeå, Sweden.
Matilda RentoftDepartment of Radiation Sciences, Oncology, Umeå University, SE-901 87 Umeå, Sweden.
Julie A SchmidtCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK.ORCID 0000-0002-7733-8750
Ruth C TravisCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK.
Elisabete WeiderpassInternational Agency for Research on Cancer, World Health Organization, 69008 Lyon, France.ORCID 0000-0003-2237-0128
Mattias JohanssonGenomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.
Laure DossusNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.ORCID 0000-0003-2716-5748
Mazda JenabNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.ORCID 0000-0002-0573-1852
Marc J GunterNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.
Justo Lorenzo BermejoStatistical Genetics Group, Institute of Medical Biometry, University of Heidelberg, 69120 Heidelberg, Germany.ORCID 0000-0002-6568-5333
Dominique SchererStatistical Genetics Group, Institute of Medical Biometry, University of Heidelberg, 69120 Heidelberg, Germany.ORCID 0000-0003-4430-296X
Reza M SalekNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.ORCID 0000-0001-8604-1732
Pekka Keski-RahkonenNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.ORCID 0000-0001-9437-3040
Pietro FerrariNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.

Funding

Cancer Research UK 29017Medical Research Council MR/M012190/1World Health Organization 001
6 · The paper itself

Abstract

Pooling metabolomics data across studies is often desirable to increase the statistical power of the analysis. However, this can raise methodological challenges as several preanalytical and analytical factors could introduce differences in measured concentrations and variability between datasets. Specifically, different studies may use variable sample types (e.g., serum versus plasma) collected, treated, and stored according to different protocols, and assayed in different laboratories using different instruments. To address these issues, a new pipeline was developed to normalize and pool metabolomics data through a set of sequential steps: (i) exclusions of the least informative observations and metabolites and removal of outliers; imputation of missing data; (ii) identification of the main sources of variability through principal component partial R-square (PC-PR2) analysis; (iii) application of linear mixed models to remove unwanted variability, including samples' originating study and batch, and preserve biological variations while accounting for potential differences in the residual variances across studies. This pipeline was applied to targeted metabolomics data acquired using Biocrates AbsoluteIDQ kits in eight case-control studies nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Comprehensive examination of metabolomics measurements indicated that the pipeline improved the comparability of data across the studies. Our pipeline can be adapted to normalize other molecular data, including biomarkers as well as proteomics data, and could be used for pooling molecular datasets, for example in international consortia, to limit biases introduced by inter-study variability. This versatility of the pipeline makes our work of potential interest to molecular epidemiologists.

Indexed as

cancer epidemiologymetabolitesmetabolomicsnormalizationpoolingtechnical variability

Identifiers

PMID34564446
PMCPMC8467830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.